|
PSMC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.426200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.995900E-03 |
| Normal-vs-Stage2 |
6.032400E-02 |
| Normal-vs-Stage3 |
1.733360E-01 |
| Normal-vs-Stage4 |
7.373400E-04 |
| Stage1-vs-Stage2 |
7.344200E-01 |
| Stage1-vs-Stage3 |
6.482800E-01 |
| Stage1-vs-Stage4 |
3.260300E-02 |
| Stage2-vs-Stage3 |
5.797400E-01 |
| Stage2-vs-Stage4 |
1.198970E-01 |
| Stage3-vs-Stage4 |
3.038100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.90430000000564E-05 |
| Normal-vs-AfricanAmerican |
9.279000E-01 |
| Normal-vs-Asian |
9.549900E-02 |
| Caucasian-vs-AfricanAmerican |
4.897900E-02 |
| Caucasian-vs-Asian |
2.570600E-01 |
| AfricanAmerican-vs-Asian |
8.043600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.994700E-04 |
| Normal-vs-Female |
2.517700E-03 |
| Male-vs-Female |
9.420400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.136800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.236100E-03 |
| Normal-vs-Age(61-80Yrs) |
6.977600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.962600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.317000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.465000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.788800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.144000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.993800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.598600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.042200E-01 |
| Normal-vs-Grade 2 |
1.407730E-02 |
| Normal-vs-Grade 3 |
2.675200E-03 |
| Normal-vs-Grade 4 |
6.699700E-03 |
| Grade 1-vs-Grade 2 |
6.317800E-01 |
| Grade 1-vs-Grade 3 |
4.989800E-01 |
| Grade 1-vs-Grade 4 |
3.163000E-01 |
| Grade 2-vs-Grade 3 |
3.073400E-01 |
| Grade 2-vs-Grade 4 |
9.275700E-02 |
| Grade 3-vs-Grade 4 |
2.810000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.119630E-03 |
| Normal-vs-ccB subtype |
4.664700E-03 |
| ccA subtype-vs-ccB subtype |
6.044200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.381100E-04 |
| Normal-vs-N1 |
2.111600E-01 |
| N0-vs-N1 |
5.511200E-01 |
|
|
